HUP0200148A3 - Use of n-(3',4'-dimethoxy-cinnamoyl)-anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention - Google Patents
Use of n-(3',4'-dimethoxy-cinnamoyl)-anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary interventionInfo
- Publication number
- HUP0200148A3 HUP0200148A3 HU0200148A HUP0200148A HUP0200148A3 HU P0200148 A3 HUP0200148 A3 HU P0200148A3 HU 0200148 A HU0200148 A HU 0200148A HU P0200148 A HUP0200148 A HU P0200148A HU P0200148 A3 HUP0200148 A3 HU P0200148A3
- Authority
- HU
- Hungary
- Prior art keywords
- cinnamoyl
- dimethoxy
- prevention
- reduction
- events associated
- Prior art date
Links
- NZHGWWWHIYHZNX-UHFFFAOYSA-N 2-((3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic acid Chemical compound C1=C(OC)C(OC)=CC=C1C=CC(=O)NC1=CC=CC=C1C(O)=O NZHGWWWHIYHZNX-UHFFFAOYSA-N 0.000 title 1
- 230000007211 cardiovascular event Effects 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11846399P | 1999-02-03 | 1999-02-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0200148A2 HUP0200148A2 (hu) | 2002-05-29 |
| HUP0200148A3 true HUP0200148A3 (en) | 2003-06-30 |
Family
ID=22378760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0200148A HUP0200148A3 (en) | 1999-02-03 | 2000-02-02 | Use of n-(3',4'-dimethoxy-cinnamoyl)-anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1180027A4 (no) |
| JP (1) | JP2002536326A (no) |
| KR (1) | KR20010101933A (no) |
| CN (1) | CN1338930A (no) |
| AR (1) | AR022475A1 (no) |
| AU (1) | AU2978500A (no) |
| BR (1) | BR0007901A (no) |
| CA (1) | CA2361578A1 (no) |
| CO (1) | CO5160246A1 (no) |
| HU (1) | HUP0200148A3 (no) |
| IL (1) | IL144719A0 (no) |
| MX (1) | MXPA01007833A (no) |
| NO (1) | NO20013789L (no) |
| PL (1) | PL349926A1 (no) |
| TR (1) | TR200102262T2 (no) |
| WO (1) | WO2000045810A1 (no) |
| ZA (1) | ZA200106297B (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8097650B2 (en) * | 2005-07-27 | 2012-01-17 | The Trustees Of Columbia University In The City Of New York | Method of treating a condition associated with phosphorylation of TASK-1 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2617407B2 (ja) * | 1992-09-14 | 1997-06-04 | キッセイ薬品工業株式会社 | 血管内膜細胞過剰増殖疾患の予防および治療剤 |
| WO1997009301A1 (fr) * | 1995-09-07 | 1997-03-13 | Kissei Pharmaceutical Co., Ltd. | Derives de 2-acylaminobenzamide, preventif et remede contre des maladies causees par une surmultiplication des cellules vasculaires de l'intima |
| US6019104A (en) * | 1996-12-30 | 2000-02-01 | Kissei Pharmaceutical Co., Ltd. | Method for the treatment or prevention of restenosis associated with coronary intervention |
-
2000
- 2000-02-02 TR TR2001/02262T patent/TR200102262T2/xx unknown
- 2000-02-02 HU HU0200148A patent/HUP0200148A3/hu unknown
- 2000-02-02 CN CN00803386A patent/CN1338930A/zh active Pending
- 2000-02-02 KR KR1020017009743A patent/KR20010101933A/ko not_active Application Discontinuation
- 2000-02-02 EP EP00908440A patent/EP1180027A4/en not_active Withdrawn
- 2000-02-02 IL IL14471900A patent/IL144719A0/xx unknown
- 2000-02-02 MX MXPA01007833A patent/MXPA01007833A/es unknown
- 2000-02-02 BR BR0007901-4A patent/BR0007901A/pt not_active Application Discontinuation
- 2000-02-02 AR ARP000100437A patent/AR022475A1/es unknown
- 2000-02-02 WO PCT/US2000/002611 patent/WO2000045810A1/en not_active Application Discontinuation
- 2000-02-02 JP JP2000596930A patent/JP2002536326A/ja not_active Withdrawn
- 2000-02-02 AU AU29785/00A patent/AU2978500A/en not_active Abandoned
- 2000-02-02 CA CA002361578A patent/CA2361578A1/en not_active Abandoned
- 2000-02-02 PL PL00349926A patent/PL349926A1/xx not_active Application Discontinuation
- 2000-02-03 CO CO00006605A patent/CO5160246A1/es unknown
-
2001
- 2001-07-31 ZA ZA200106297A patent/ZA200106297B/en unknown
- 2001-08-02 NO NO20013789A patent/NO20013789L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA01007833A (es) | 2002-06-21 |
| ZA200106297B (en) | 2002-07-31 |
| TR200102262T2 (tr) | 2002-02-21 |
| JP2002536326A (ja) | 2002-10-29 |
| IL144719A0 (en) | 2002-06-30 |
| CA2361578A1 (en) | 2000-08-10 |
| HUP0200148A2 (hu) | 2002-05-29 |
| CN1338930A (zh) | 2002-03-06 |
| EP1180027A1 (en) | 2002-02-20 |
| WO2000045810A1 (en) | 2000-08-10 |
| NO20013789D0 (no) | 2001-08-02 |
| CO5160246A1 (es) | 2002-05-30 |
| EP1180027A4 (en) | 2004-11-17 |
| AU2978500A (en) | 2000-08-25 |
| BR0007901A (pt) | 2001-10-30 |
| PL349926A1 (en) | 2002-10-21 |
| AR022475A1 (es) | 2002-09-04 |
| NO20013789L (no) | 2001-09-28 |
| KR20010101933A (ko) | 2001-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0201103A3 (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
| IL145732A0 (en) | α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| PL352100A1 (en) | Antagonists of the beta 2 adrenoreceptor | |
| PL348349A1 (en) | Antrhranilic acid amides and the use thereof as medicaments | |
| HUP0200638A2 (en) | Compounds derived from benzoic acid esters, composition containing said compounds and use thereof | |
| HUP0102255A3 (en) | Vla-4 inhibitor omepupa-v, pharmaceutical compositions comprising thereof and their use | |
| IL129270A0 (en) | Class "d" amplifier | |
| HU9500063D0 (en) | Alfa-pyrimidinyl acrylic acid derivatives, the preparation thereof and their use as fungicide | |
| HUP0203611A3 (en) | 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments | |
| PL353214A1 (en) | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors | |
| HUP0200148A3 (en) | Use of n-(3',4'-dimethoxy-cinnamoyl)-anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention | |
| AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
| Ways | THEIR MEANING | |
| IT1271417B (it) | Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono. | |
| HUP0201729A3 (en) | Inhibitors of the integrin alpha v betha 6 | |
| HUP0200129A3 (en) | Use of n-(3'4'-dimethoxycinnamoyl) anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention | |
| IL149607A0 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3 benzazocines and the use thereof as medicaments | |
| EP1172359A4 (en) | N-SUBSTITUTED-N'-SUBSTITUTED UREA DERIVATIVE, AND ITS USE AS AN INHIBITOR OF TNF PRODUCTION- $ g (a) | |
| HK1045506A1 (en) | Oxathiepino 6,5- i b /iÜdihydropyridines, and related compositions and methods | |
| SI1235809T1 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments | |
| IL129642A0 (en) | Process for the preparation of optically active 1,4-benzodioxane-2- carboxylic acid and derivatives thereof | |
| ZA997090B (en) | "A composition for the treatment of wood". | |
| SI1214302T1 (en) | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors | |
| ZA997168B (en) | "Shelving". | |
| ZA981918B (en) | Use of 2,3,4,5-tetrahydro-1H-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders |